All Regulatory Enforcement articles – Page 128

  • Blog

    State Street to pay $35M for disclosure failures

    2017-09-07T12:00:00Z

    State Street today agreed to pay more than $35 million to settle charges that it fraudulently charged secret markups for transition management services and separately omitted material information about the operation of its platform for trading U.S. Treasury securities.

  • Blog

    New scandals; new lexicon for unethical conduct

    2017-09-06T15:00:00Z

    In the FCPA world, the most dreaded question during an enforcement action is “where else?”—as in, where else are you engaging in bribery and corruption? After Wells Fargo, the lexicon may well expand to “what else?”—as in what other conduct is your company engaging in that is unethical?

  • Blog

    Going weird in international bribery and corruption

    2017-09-06T15:00:00Z

    As Hunter S. Thompson once said, “When the going gets weird, the weird turn pro.” Such is the case of BSG Resources after accusations surfaced that the company had paid bribes to obtain a huge mining concession in Guinea—charges it vehemently denies.

  • Article

    FOR: Neither admit nor deny

    2017-09-06T12:15:00Z

    Allowing firms to enter into consent judgments without having to admit material facts or liability prevents excessive disruption of the regulatory/enforcement framework. Read more from Paul Weiss litigators Brad Karp and Susanna Buergel.

  • Article

    AGAINST: Neither admit nor deny

    2017-09-06T12:00:00Z

    Allowing defendants to settle cases without admitting or denying guilt deprives the public of transparency and accountability. The Honorable Judge Jed Rakoff for the United States District Court explores below.

  • Blog

    For leniency, confess all crimes

    2017-09-05T16:45:00Z

    The JBS meat-packing scandal is a perfect example of why companies must provide every single shred of evidence of criminal conduct, or a plea agreement might not be worth much.

  • Blog

    There will be blood

    2017-09-05T14:15:00Z

    A viral video of a nurse who was arrested for upholding her hospital’s own policy on permitting blood draws from non-consenting patients highlights the true challenges of compliance.

  • Blog

    SEC names director of DERA

    2017-09-05T10:45:00Z

    The Securities and Exchange Commission has named Jeffrey Harris as director of the agency's Division of Economic and Risk Analysis (DERA).  He replaces former director Mark Flannery, who left the agency to return to teaching.

  • Blog

    Chairman Clayton names executive staff

    2017-09-05T10:30:00Z

    The Securities and Exchange Commission has named seven individuals to the executive staff of Chairman Jay Clayton.

  • Blog

    What are the effects of C-Suite involvement in bribery and corruption?

    2017-08-28T15:00:00Z

    A look at the corruption cases of Samsung and Panalpina and the outcome from when C-Suite becomes involved in corporate bribery and corruption schemes.

  • Blog

    Preparing for compliance

    2017-08-28T14:30:00Z

    One lsson learned from Hurricane Harvey applies to today’s compliance professional: You must do more than prepare for a compliance emergency by preparing beforehand, but you must also practice that preparedness.

  • Blog

    Will Uber change its toxic culture?

    2017-08-28T14:30:00Z

    The Man From FCPA explores what the future has in store for Uber Technologies under new chief executive Dara Khosrowshahi.

  • Article

    Compliance remedies for new sanction headaches

    2017-08-22T13:30:00Z

    Compliance officers will want to reevaluate their trade sanction compliance policies, following new sanctions legislation signed into law this month.

  • Blog

    Scam and money laundering puts former Wells Fargo manager in jail

    2017-08-22T12:45:00Z

    A former Wells Frago bank manager is headed to jail for his role in a $1.66 million mass mailing scam that was facilitated with a money laundering scheme.

  • Blog

    Medical device CEO convicted of $750 million securities fraud

    2017-08-22T12:30:00Z

    A federal jury has convicted the former chief executive officer of a publicly traded medical device compan for his role in orchestrating a fraud scheme that led to $750 million in shareholder losses.

  • Blog

    Mylan will pay $465 million to resolve False Claims Act liability

    2017-08-22T12:15:00Z

    Mylan, maker of the EpiPen, has agreed to pay $465 million to settle Department of Justice allegations that it violated the False Claims Act by misclassifying the epinephrine injector  as a generic drug to avoid paying Medicaid rebates.

  • Blog

    Hedge fund adviser charged with inadequate insider trading controls

    2017-08-22T12:00:00Z

    A hedge fund advisory firm  has agreed to pay more than $4.6 million to settle SEC charges that it had inadequate policies and procedures to prevent the misuse of inside information, including information about confidential government decisions.

  • Blog

    NLRB compliance officer fabricated victims, stole from compensation fund

    2017-08-22T11:45:00Z

    A former NLRB compliance officer pleaded guilty this week to charges he stole more than $400,000 from an agency fund he oversaw that was intended to distribute funds to employees victimized by labor law violations.

  • Blog

    Another CCO settles with SEC over negligence of duties

    2017-08-21T14:00:00Z

    The SEC has announced another settlement with a former CCO over alleged negligence. The settlement, reached on Aug. 15 also offers a caution about retaining third party compliance services.

  • Blog

    FCPA, CEOs and risk assessments

    2017-08-15T09:15:00Z

    Ian Narev, chief executive officer of the Commonwealth Bank of Australia, may soon join the ranks of those CEOs who depart once a corruption scandal goes public.